Show simple item record

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for prostate cancer Genetics using novel sumLINK and sumLOD analyses

dc.contributor.authorChristensen, G. Bryceen_US
dc.contributor.authorBaffoe-Bonnie, Agnes B.en_US
dc.contributor.authorGeorge, Ashaen_US
dc.contributor.authorPowell, Isaacen_US
dc.contributor.authorBailey-Wilson, Joan E.en_US
dc.contributor.authorCarpten, John D.en_US
dc.contributor.authorGiles, Graham G.en_US
dc.contributor.authorHopper, John L.en_US
dc.contributor.authorSeveri, Gianlucaen_US
dc.contributor.authorEnglish, Dallas R.en_US
dc.contributor.authorFoulkes, William D.en_US
dc.contributor.authorMaehle, Loviseen_US
dc.contributor.authorMoller, Palen_US
dc.contributor.authorEeles, Rosen_US
dc.contributor.authorEaston, Douglasen_US
dc.contributor.authorBadzioch, Michael D.en_US
dc.contributor.authorWhittemore, Alice S.en_US
dc.contributor.authorOakley-Girvan, Ingriden_US
dc.contributor.authorHsieh, Chih-Linen_US
dc.contributor.authorDimitrov, Latchezaren_US
dc.contributor.authorXu, Jianfengen_US
dc.contributor.authorStanford, Janet L.en_US
dc.contributor.authorJohanneson, Boen_US
dc.contributor.authorDeutsch, Kerryen_US
dc.contributor.authorMcIntosh, Lauraen_US
dc.contributor.authorOstrander, Elaine A.en_US
dc.contributor.authorWiley, Kathleen E.en_US
dc.contributor.authorIsaacs, Sarah D.en_US
dc.contributor.authorWalsh, Patrick C.en_US
dc.contributor.authorIsaacs, William B.en_US
dc.contributor.authorThibodeau, Stephen N.en_US
dc.contributor.authorMcDonnell, Shannon K.en_US
dc.contributor.authorHebbring, Scotten_US
dc.contributor.authorSchaid, Daniel J.en_US
dc.contributor.authorLange, Ethan M.en_US
dc.contributor.authorCooney, Kathleen A.en_US
dc.contributor.authorTammela, Teuvo L. J.en_US
dc.contributor.authorSchleutker, Johannaen_US
dc.contributor.authorPaiss, Thomasen_US
dc.contributor.authorMaier, Christianeen_US
dc.contributor.authorGrönberg, Henriken_US
dc.contributor.authorWiklund, Fredriken_US
dc.contributor.authorEmanuelsson, Monicaen_US
dc.contributor.authorFarnham, James M.en_US
dc.contributor.authorCannon-Albright, Lisa A.en_US
dc.contributor.authorCamp, Nicola J.en_US
dc.date.accessioned2010-05-07T18:07:34Z
dc.date.available2011-03-01T16:26:45Zen_US
dc.date.issued2010-05-15en_US
dc.identifier.citationChristensen, G. Bryce; Baffoe-Bonnie, Agnes B.; George, Asha; Powell, Isaac; Bailey-Wilson, Joan E.; Carpten, John D.; Giles, Graham G.; Hopper, John L.; Severi, Gianluca; English, Dallas R.; Foulkes, William D.; Maehle, Lovise; Moller, Pal; Eeles, Ros; Easton, Douglas; Badzioch, Michael D.; Whittemore, Alice S.; Oakley-Girvan, Ingrid; Hsieh, Chih-Lin; Dimitrov, Latchezar; Xu, Jianfeng; Stanford, Janet L.; Johanneson, Bo; Deutsch, Kerry; McIntosh, Laura; Ostrander, Elaine A.; Wiley, Kathleen E.; Isaacs, Sarah D.; Walsh, Patrick C.; Isaacs, William B.; Thibodeau, Stephen N.; McDonnell, Shannon K.; Hebbring, Scott; Schaid, Daniel J.; Lange, Ethan M.; Cooney, Kathleen A.; Tammela, Teuvo L.J.; Schleutker, Johanna; Paiss, Thomas; Maier, Christiane; GrÖnberg, Henrik; Wiklund, Fredrik; Emanuelsson, Monica; Farnham, James M.; Cannon-Albright, Lisa A.; Camp, Nicola J. (2010). "Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for prostate cancer Genetics using novel sumLINK and sumLOD analyses." The Prostate 70(7): 735-744. <http://hdl.handle.net/2027.42/71371>en_US
dc.identifier.issn0270-4137en_US
dc.identifier.issn1097-0045en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71371
dc.description.abstractBACKGROUND Prostate cancer (PC) is generally believed to have a strong inherited component, but the search for susceptibility genes has been hindered by the effects of genetic heterogeneity. The recently developed sumLINK and sumLOD statistics are powerful tools for linkage analysis in the presence of heterogeneity. METHODS We performed a secondary analysis of 1,233 PC pedigrees from the International Consortium for Prostate Cancer Genetics (ICPCG) using two novel statistics, the sumLINK and sumLOD. For both statistics, dominant and recessive genetic models were considered. False discovery rate (FDR) analysis was conducted to assess the effects of multiple testing. RESULTS Our analysis identified significant linkage evidence at chromosome 22q12, confirming previous findings by the initial conventional analyses of the same ICPCG data. Twelve other regions were identified with genome-wide suggestive evidence for linkage. Seven regions (1q23, 5q11, 5q35, 6p21, 8q12, 11q13, 20p11–q11) are near loci previously identified in the initial ICPCG pooled data analysis or the subset of aggressive PC pedigrees. Three other regions (1p12, 8p23, 19q13) confirm loci reported by others, and two (2p24, 6q27) are novel susceptibility loci. FDR testing indicates that over 70% of these results are likely true positive findings. Statistical recombinant mapping narrowed regions to an average of 9 cM. CONCLUSIONS Our results represent genomic regions with the greatest consistency of positive linkage evidence across a very large collection of high-risk PC pedigrees using new statistical tests that deal powerfully with heterogeneity. These regions are excellent candidates for further study to identify PC predisposition genes. Prostate 70: 735–744, 2010. © 2010 Wiley-Liss, Inc.en_US
dc.format.extent219326 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherCancer Research, Oncology and Pathologyen_US
dc.titleGenome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for prostate cancer Genetics using novel sumLINK and sumLOD analysesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan ICPCG Group ; Department of Genetics, University of North Carolina, Chapel Hill, North Carolinaen_US
dc.contributor.affiliationumUniversity of Michigan ICPCG Group ; University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherUniversity of Utah ICPCG Group and Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah ; Division of Genetic Epidemiology, University of Utah School of Medicine, 391, Chipeta Way, Suite D, Salt Lake City, UT 84108.en_US
dc.contributor.affiliationotherAfrican American Hereditary Prostate Cancer ICPCG Group ; Fox Chase Cancer Center, Philadelphia, Pennsylvania ; National Human Genome Research Institute, NIH, Bethesda, Marylanden_US
dc.contributor.affiliationotherAfrican American Hereditary Prostate Cancer ICPCG Group ; Fox Chase Cancer Center, Philadelphia, Pennsylvaniaen_US
dc.contributor.affiliationotherAfrican American Hereditary Prostate Cancer ICPCG Group ; Karmanos Cancer Institute, Wayne State University, Detroit, Michiganen_US
dc.contributor.affiliationotherAfrican American Hereditary Prostate Cancer ICPCG Group ; National Human Genome Research Institute, NIH, Bethesda, Marylanden_US
dc.contributor.affiliationotherAfrican American Hereditary Prostate Cancer ICPCG Group ; Translational Genomics Research Institute, Genetic Basis of Human Disease Research Division, Phoenix, Arizonaen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australiaen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australiaen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australiaen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australiaen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Department of Oncology, McGill University, Montreal, Quebec, Canadaen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; The Norwegian Radium Hospital, Oslo, Norwayen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; The Norwegian Radium Hospital, Oslo, Norwayen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Surrey, UKen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Cancer Research UK Genetic Epidemiology Unit, Cambridge, UKen_US
dc.contributor.affiliationotherACTANE Consortium ICPCG Group ; Division of Medical Genetics, University of Washington Medical Center, Seattle, Washingtonen_US
dc.contributor.affiliationotherBC/CA/HI ICPCG Group ; Department of Health Research and Policy, Stanford School of Medicine, Stanford, California ; Stanford Comprehensive Cancer Center, Stanford School of Medicine, Stanford, Californiaen_US
dc.contributor.affiliationotherBC/CA/HI ICPCG Group ; Stanford Comprehensive Cancer Center, Stanford School of Medicine, Stanford, Californiaen_US
dc.contributor.affiliationotherBC/CA/HI ICPCG Group ; Department of Urology and Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, Californiaen_US
dc.contributor.affiliationotherData Coordinating Center for the ICPCG and Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolinaen_US
dc.contributor.affiliationotherData Coordinating Center for the ICPCG and Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolinaen_US
dc.contributor.affiliationotherFHCRC ICPCG Group ; Fred Hutchinson Cancer Research Center, Divisions of Public Health Sciences, Seattle, Washingtonen_US
dc.contributor.affiliationotherFHCRC ICPCG Group ; Cancer Genetics Branch, National Institutes of Health, Bethesda, Marylanden_US
dc.contributor.affiliationotherFHCRC ICPCG Group ; Institute for Systems Biology, Seattle, Washingtonen_US
dc.contributor.affiliationotherFHCRC ICPCG Group ; Fred Hutchinson Cancer Research Center, Divisions of Public Health Sciences, Seattle, Washingtonen_US
dc.contributor.affiliationotherFHCRC ICPCG Group ; Cancer Genetics Branch, National Institutes of Health, Bethesda, Marylanden_US
dc.contributor.affiliationotherJohns Hopkins University ICPCG Group and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Marylanden_US
dc.contributor.affiliationotherJohns Hopkins University ICPCG Group and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Marylanden_US
dc.contributor.affiliationotherJohns Hopkins University ICPCG Group and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Marylanden_US
dc.contributor.affiliationotherJohns Hopkins University ICPCG Group and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Marylanden_US
dc.contributor.affiliationotherMayo Clinic ICPCG Group and Mayo Clinic, Rochester, Minnesotaen_US
dc.contributor.affiliationotherMayo Clinic ICPCG Group and Mayo Clinic, Rochester, Minnesotaen_US
dc.contributor.affiliationotherMayo Clinic ICPCG Group and Mayo Clinic, Rochester, Minnesotaen_US
dc.contributor.affiliationotherMayo Clinic ICPCG Group and Mayo Clinic, Rochester, Minnesotaen_US
dc.contributor.affiliationotherUniversity of Tampere ICPCG Group, University of Tampere and Tampere University Hospital, Tampere, Finlanden_US
dc.contributor.affiliationotherUniversity of Tampere ICPCG Group, University of Tampere and Tampere University Hospital, Tampere, Finlanden_US
dc.contributor.affiliationotherUniversity of Ulm ICPCG Group ; Department of Urology, University of Ulm, Ulm, Germanyen_US
dc.contributor.affiliationotherUniversity of Ulm ICPCG Group ; Institute of Human Genetics, University of Ulm, Ulm, Germanyen_US
dc.contributor.affiliationotherUniversity of UmeÅ ICPCG Group ; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Swedenen_US
dc.contributor.affiliationotherUniversity of UmeÅ ICPCG Group ; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Swedenen_US
dc.contributor.affiliationotherUniversity of UmeÅ ICPCG Group ; Oncologic Centre, UmeÅ University, UmeÅ, Swedenen_US
dc.contributor.affiliationotherUniversity of Utah ICPCG Group and Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, Utahen_US
dc.contributor.affiliationotherUniversity of Utah ICPCG Group and Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, Utahen_US
dc.contributor.affiliationotherUniversity of Utah ICPCG Group and Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, Utahen_US
dc.identifier.pmid20333727en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71371/1/21106_ftp.pdf
dc.identifier.doi10.1002/pros.21106en_US
dc.identifier.sourceThe Prostateen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.